JNK inhibitors specifically target c-Jun N-terminal kinases, a subgroup of MAP kinases involved in stress responses, apoptosis, and inflammation. These reagents are used to investigate JNK-mediated pathways in cellular models of neurodegeneration, ischemia, and immune responses.
The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page